Logotipo do repositório

Recent advances in the development of antimicrobial peptides against ESKAPE pathogens

Resumo

Multi-drug resistant ESKAPE pathogens (<i>Enterococcus faecium</i>, <i>Staphylococcus</i> aureus, <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, and Enterobacter species) are a global health threat. The severity of the problem lies in its impact on mortality, therapeutic limitations, the threat to public health, and the costs associated with managing infections caused by these resistant strains. Effectively addressing this challenge requires innovative approaches to research, the development of new antimicrobials, and more responsible antibiotic use practices globally. Antimicrobial peptides (AMPs) are a part of the innate immune system of all higher organisms. They are short, cationic and amphipathic molecules with broad-spectrum activity. AMPs interact with the negatively charged bacterial membrane. In recent years, AMPs have attracted considerable interest as potential antibiotics. However, AMPs have low bioavailability and short half-lives, which may be circumvented by chemical modification. This review presents recent <i>in vitro</i> and <i>in silico</i> strategies for the modification of AMPs to improve their stability and application in preclinical experiments.

Descrição

Palavras-chave

Citação

Financiadores

Publicações relacionadas

Unidades

Tipo de item:Unidade,
Araraquara, Faculdade de Ciências Farmacêuticas - FCF
FCF
Campus: Araraquara

Departamentos

Cursos de graduação

Programas de pós-graduação

Outras formas de acesso